News

Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...
Noom will start offering microdoses of compounded Wegovy (NVO), the blockbuster weight-loss drug, as the digital health ...
When considering a weight loss medication — or any medication — it’s normal to wonder when the effects will kick in.
Some doubt has been cast on the future of pharma firm Novo Nordisk after its ousting... The FTSE 100 opened in the green on Tuesday as shares in Diploma Plc climbed 15 per... US drugmaker Pfizer said ...
Novo Nordisk, the company that makes Wegovy and Ozempic, is abruptly ousting its chief executive over concerns the firm is ...
The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
Many people using GLP-1 weight-loss drugs like Ozempic, Wegovy or Mounjaro regain the weight after stopping-experts explain ...
Weight-loss jab Mounjaro helps people shed significantly more weight than rival Wegovy, new research suggests.
The Danish diabetes drug is now officially available for weight loss in Czechia, offering a medically supervised option to ...
It’s illegal to advertise prescription drugs. Novo Nordisk, which makes Ozempic and Wegovy, has not named any drugs in its ...
Obesity drugmaker Novo Nordisk has today downgraded its 2025 sales forecast, ending a four-year stretch of steady guidance ...